Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Silo Pharma has entered into definitive agreements for a private placement to raise approximately $4 million in upfront gross proceeds by selling 619,965 shares of common stock at $6.452 per share. The offering includes Series A-3 and Series A-4 warrants exercisable immediately at $6.21 per share, which could generate an additional $7.7 million if fully exercised, bringing the total potential gross proceeds to roughly $11.7 million. H.C. Wainwright & Co.
Key figures
- Deal Value Usd
- 4000000
- Offering Price
- 6.452
- Shares Offered
- 619965
- Warrant exercise price
- 6.21
- Potential warrant proceeds usd
- 7700000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.